Genomic characterisation reveals a dominant lineage of SARS-CoV-2 in Papua New Guinea

Virus Evol. 2022 Apr 7;8(1):veac033. doi: 10.1093/ve/veac033. eCollection 2022 Apr.

Abstract

The coronavirus disease pandemic has highlighted the utility of pathogen genomics as a key part of comprehensive public health response to emerging infectious diseases threats, however, the ability to generate, analyse, and respond to pathogen genomic data varies around the world. Papua New Guinea (PNG), which has limited in-country capacity for genomics, has experienced significant outbreaks of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with initial genomics data indicating a large proportion of cases were from lineages that are not well defined within the current nomenclature. Through a partnership between in-country public health agencies and academic organisations, industry, and a public health genomics reference laboratory in Australia a system for routine SARS-CoV-2 genomics from PNG was established. Here we aim to characterise and describe the genomics of PNG's second wave and examine the sudden expansion of a lineage that is not well defined but very prevalent in the Western Pacific region. We generated 1797 sequences from cases in PNG and performed phylogenetic and phylodynamic analyses to examine the outbreak and characterise the circulating lineages and clusters present. Our results reveal the rapid expansion of the B.1.466.2 and related lineages within PNG, from multiple introductions into the country. We also highlight the difficulties that unstable lineage assignment causes when using genomics to assist with rapid cluster definitions.

Keywords: AU.1; AU.3; B.1.459; B.1.466.2; PNG Covid-19; PNG SARS-CoV-2; PNG genomic sequencing; PNG lineage; Pacific Islands SARS-CoV-2; Pacific lineage; Papua New Guinea SARS-CoV-2; genomic sequencing capacity.